Cargando…

What is the impact of PPAR-γ agonist-rosiglitazone on ovarian reserve after hysterectomy? An experimental study

BACKGROUND/AIM: To evaluate the effects of hysterectomy on rat ovaries and the possible protective role of peroxisome proliferator-activated receptor gamma (PPAR-γ) agonist-rosiglitazone against ovarian reserve decrement. MATERIALS AND METHODS: Forty-five adult Wistar albino rats were randomly divid...

Descripción completa

Detalles Bibliográficos
Autores principales:	GÜNDOĞDU, Burcu, TAPISIZ, Ömer Lütfi, DİLBAZ, Berna, MÜLAZIMOĞLU, Serkan Barış, MÜFTÜOĞLU, Kamil Hakan, DÜNDAR, Betül, GÖKTOLGA, Ümit
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Scientific and Technological Research Council of Turkey 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7491268/ https://www.ncbi.nlm.nih.gov/pubmed/32394682 http://dx.doi.org/10.3906/sag-2002-117

Ejemplares similares

Outcomes of robotic, laparoscopic, and open hysterectomy for benign conditions in obese patients
por: Borahay, Mostafa A., et al.
Publicado: (2018)

Laparoscopic hemi-hysterectomy in a noncommunicating uterine horn: The critical steps to be considered
por: Kıykaç Altınbaş, Şadıman, et al.
Publicado: (2020)

Does screening for vaginal infection have an impact on pregnancy rates in intracytoplasmic sperm injection cycles?
por: Eldivan, Özlem, et al.
Publicado: (2016)

Rosiglitazone activation of PPARγ suppresses fractalkine signaling
por: Wan, Yihong, et al.
Publicado: (2010)

The impact of different etiologies of diminished ovarian reserve on pregnancy outcome in IVF-ET cycles
por: ÖZELÇİ, Runa, et al.
Publicado: (2019)

Antineoplastic effects of rosiglitazone and PPARγ transactivation in neuroblastoma cells
por: Cellai, I, et al.
Publicado: (2006)

Only Female Age, and Not Blood Type, Is Associated with Ovarian Reserve
por: Şengül, Özlem, et al.
Publicado: (2014)

Clinical significance of serum and follicular fluid ceramide levels in women with low ovarian reserve
por: Timur, Burcu, et al.
Publicado: (2022)

The PPARγ Agonist Rosiglitazone Impairs Colonic Inflammation in Mice with Experimental Colitis
por: Ramakers, Julian D., et al.
Publicado: (2007)

The PPARγ Agonist Rosiglitazone Enhances the Radiosensitivity of Human Pancreatic Cancer Cells
por: Wang, Zhenyu, et al.
Publicado: (2020)

Gynecological laparoscopic surgery in the shade of COVID-19 pandemic
por: KIYKAÇ ALTINBAŞ, Şadıman, et al.
Publicado: (2020)

The effects of PPARγ agonist rosiglitazone on neointimal hyperplasia in rabbit carotid anastomosis model
por: Guzeloglu, Mehmet, et al.
Publicado: (2012)

Macrophage PPARγ inhibits Gpr132 to mediate the anti-tumor effects of rosiglitazone
por: Cheng, Wing Yin, et al.
Publicado: (2016)

Induction of PPAR Gamma mRNA and Protein Expression by Rosiglitazone in Chronic Cyclosporine Nephropathy in the Rat
por: Ahn, Kyung Ohk, et al.
Publicado: (2007)

Electroacupuncture Reduces Weight Gain Induced by Rosiglitazone through PPARγ and Leptin Receptor in CNS
por: Jing, Xinyue, et al.
Publicado: (2016)

Identification of novel multitargeted PPARα/γ/δ pan agonists by core hopping of rosiglitazone
por: Wang, Xue-Jiao, et al.
Publicado: (2014)

Anti-diabetic rosiglitazone remodels the adipocyte transcriptome by redistributing transcription to PPARγ-driven enhancers
por: Step, Sonia E., et al.
Publicado: (2014)

Expression of GPR43 in Brown Adipogenesis Is Enhanced by Rosiglitazone and Controlled by PPARγ/RXR Heterodimerization
por: Hu, Jiamiao, et al.
Publicado: (2018)

Anticancer Effect of Rosiglitazone, a PPAR-γ Agonist against Diethylnitrosamine-Induced Lung Carcinogenesis
por: Wu, Yanqiao, et al.
Publicado: (2020)

Rosiglitazone-Mediated Activation of PPARγ Restores HO1 Expression in the Human Preeclamptic Placenta
por: Grimaldi, Brooke, et al.
Publicado: (2023)

Determination of the Risk Factors That Influence Occurrence Time of Traffic Accidents with Survival Analysis
por: ORALHAN, Burcu, et al.
Publicado: (2018)

The PPARγ Agonist Rosiglitazone Is Antifibrotic for Scleroderma Lung Fibroblasts: Mechanisms of Action and Differential Racial Effects
por: Bogatkevich, Galina S., et al.
Publicado: (2012)

Activation of PPARγ by Rosiglitazone Does Not Negatively Impact Male Sex Steroid Hormones in Diabetic Rats
por: Mansour, Mahmoud, et al.
Publicado: (2009)

Retraction of “Anticancer Effect of Rosiglitazone, a PPAR-γ Agonist against Diethylnitrosamine-Induced Lung Carcinogenesis”
por: Wu, Yanqiao, et al.
Publicado: (2021)

Leukemia and rosiglitazone
por: Yavasoglu, Irfan, et al.
Publicado: (2016)

Rosiglitazone Restores Endothelial Dysfunction in a Rat Model of Metabolic Syndrome through PPARγ- and PPARδ-Dependent Phosphorylation of Akt and eNOS
por: Zhao, Zhigang, et al.
Publicado: (2011)

Squamous cell carcinoma of the vulva in a virgin patient with Turner syndrome
por: Tapisiz, Omer Lutfi, et al.
Publicado: (2011)

The Manchester procedure combined with laparoscopic sacrohysteropexy by retroperitoneal tunneling
por: Seçkin, Kerem Doğa, et al.
Publicado: (2022)

Feasibility and Safety of Laparoscopic Surgery in Large Ovarian Masses
por: Kinay, Tugba, et al.
Publicado: (2022)

Are women with polycystic ovary syndrome more vulnerable to COVID-19 infection?
por: Dilbaz, Berna
Publicado: (2021)

Editorial: Highlights in contraception and family planning 2021/22
por: Dilbaz, Berna
Publicado: (2023)

Influence of Rosiglitazone on the Expression of PPARγ, NF-κB, and TNF-α in Rat Model of Ulcerative Colitis
por: Mao, Jing-Wei, et al.
Publicado: (2012)

Hepatocyte-Specific Loss of PPARγ Protects Mice From NASH and Increases the Therapeutic Effects of Rosiglitazone in the Liver
por: Lee, Samuel M., et al.
Publicado: (2021)

Expression of peroxisome proliferator-activated receptor (PPAR)-α and PPAR-γ in the lung tissue of obese mice and the effect of rosiglitazone on proinflammatory cytokine expressions in the lung tissue
por: Ryu, Seung Lok, et al.
Publicado: (2013)

The Janus face of rosiglitazone
por: Pich, Christine, et al.
Publicado: (2018)

Which one is safer – performing a laparoscopic hysterectomy with a tissue fusion device involving diagnostic cystoscopy or traditional abdominal hysterectomy with ureteral dissection?
por: Yavuzcan, Ali, et al.
Publicado: (2013)

PPARγ Agonist Rosiglitazone Suppresses Renal mPGES-1/PGE2 Pathway in db/db Mice
por: Sun, Ying, et al.
Publicado: (2013)

Rosiglitazone via PPARγ-dependent suppression of oxidative stress attenuates endothelial dysfunction in rats fed homocysteine thiolactone
por: Yang, Xu-Hong, et al.
Publicado: (2015)

Rosiglitazone suppresses RANKL‐induced NFATc1 autoamplification by disrupting the physical interaction between NFATc1 and PPARγ
por: Park, Kyeong‐Lok, et al.
Publicado: (2018)

Rosiglitazone, a Ligand to PPARγ, Improves Blood Pressure and Vascular Function through Renin-Angiotensin System Regulation
por: Sánchez-Aguilar, María, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_dl8l1lsnno4tbn8omm0mvuuid1